EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX: NIPH)

NIPH Statistics

Total Valuation

EI- Nile Co. for Pharmaceuticals and Chemical Industries has a market cap or net worth of EGP 895.46 million. The enterprise value is 1.44 billion.

Market Cap	895.46M
Enterprise Value	1.44B

Important Dates

The last earnings date was Thursday, September 19, 2024.

Earnings Date	Sep 19, 2024
Ex-Dividend Date	n/a

Share Statistics

EI- Nile Co. for Pharmaceuticals and Chemical Industries has 10.13 million shares outstanding.

Shares Outstanding	10.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.93%
Owned by Institutions (%)	n/a
Float	2.16M

Valuation Ratios

The trailing PE ratio is 9.92.

PE Ratio	9.92
Forward PE	n/a
PS Ratio	0.78
PB Ratio	1.91
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.24, with an EV/FCF ratio of -9.23.

EV / Earnings	15.92
EV / Sales	1.26
EV / EBITDA	9.24
EV / EBIT	10.01
EV / FCF	-9.23

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 1.23.

Current Ratio	1.28
Quick Ratio	0.35
Debt / Equity	1.23
Debt / EBITDA	3.70
Debt / FCF	-3.70
Interest Coverage	5.67

Financial Efficiency

Return on equity (ROE) is 19.05% and return on invested capital (ROIC) is 10.34%.

Return on Equity (ROE)	19.05%
Return on Assets (ROA)	7.14%
Return on Capital (ROIC)	10.34%
Revenue Per Employee	457,034
Profits Per Employee	36,090
Employee Count	2,500
Asset Turnover	0.91
Inventory Turnover	2.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +103.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+103.91%
50-Day Moving Average	71.31
200-Day Moving Average	77.03
Relative Strength Index (RSI)	87.23
Average Volume (20 Days)	12,542

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EI- Nile Co. for Pharmaceuticals and Chemical Industries had revenue of EGP 1.14 billion and earned 90.23 million in profits. Earnings per share was 8.91.

Revenue	1.14B
Gross Profit	252.44M
Operating Income	143.52M
Pretax Income	108.24M
Net Income	90.23M
EBITDA	155.52M
EBIT	143.52M
Earnings Per Share (EPS)	8.91

Balance Sheet

The company has 34.35 million in cash and 575.28 million in debt, giving a net cash position of -540.93 million or -53.42 per share.

Cash & Cash Equivalents	34.35M
Total Debt	575.28M
Net Cash	-540.93M
Net Cash Per Share	-53.42
Equity (Book Value)	468.86M
Book Value Per Share	46.31
Working Capital	183.82M

Cash Flow

In the last 12 months, operating cash flow was 264.11 million and capital expenditures -419.69 million, giving a free cash flow of -155.57 million.

Operating Cash Flow	264.11M
Capital Expenditures	-419.69M
Free Cash Flow	-155.57M
FCF Per Share	-15.37

Margins

Gross margin is 22.09%, with operating and profit margins of 12.56% and 7.90%.

Gross Margin	22.09%
Operating Margin	12.56%
Pretax Margin	9.47%
Profit Margin	7.90%
EBITDA Margin	13.61%
EBIT Margin	12.56%
FCF Margin	-13.62%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.26%.

Dividend Per Share	2.00
Dividend Yield	2.26%
Dividend Growth (YoY)	68.35%
Years of Dividend Growth	3
Payout Ratio	71.36%
Buyback Yield	n/a
Shareholder Yield	2.26%
Earnings Yield	10.08%
FCF Yield	-17.37%

Stock Splits

The last stock split was on January 20, 2011. It was a forward split with a ratio of 1.5.

Last Split Date	Jan 20, 2011
Split Type	Forward
Split Ratio	1.5

Scores

EI- Nile Co. for Pharmaceuticals and Chemical Industries has an Altman Z-Score of 1.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.99
Piotroski F-Score	n/a